GlassScriptPhysician profile
Alma J Hall
NPI 1659628949
$1,371.00
in general payments reported to CMS, 2019-2025
16 companies · $286 in 2025
The $286 reported for 2025 was more than what 84% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $49.10 · 2022: $327 · 2023: $326 · 2024: $383 · 2025: $286.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $995.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $994.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $416.97 | 2022-2025 | Azstarys |
| Tris Pharma INC | $262.95 | 2022-2025 | Dyanavel Xr |
| Ironshore Pharmaceuticals INC. | $172.24 | 2022-2024 | Jornay Pm |
| Supernus Pharmaceuticals, INC. | $127.63 | 2021-2025 | Qelbree |
| Sanofi Pasteur INC. | $65.44 | 2022-2023 | |
| Pfizer INC. | $64.43 | 2023-2025 | |
| Collegium Pharmaceutical, INC. | $62.63 | 2025 | Jornay Pm |
| Neurelis, INC. | $38.07 | 2023 | Valtoco |
| Merck Sharp & Dohme LLC | $30.08 | 2022 | |
| Vertical Pharmaceuticals, LLC | $28.06 | 2024-2025 | Relexxii |
| Astrazeneca Pharmaceuticals LP | $23.63 | 2024 | Flumist Quadrivalent |
| Glaxosmithkline, LLC. | $20.04 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $16.48 | 2022 | |
| Cranial Technologies, INC | $14.89 | 2023 | Doc Band |
| Sobi, INC | $14.01 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Adlon Therapeutics L.P. | $13.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alma Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.